BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38436618)

  • 1. Can cell-free DNA (cfDNA) in pleural lavage serve as a predictive and prognostic biomarker among surgically treated Stage I-III a nonsmall cell lung cancer (NSCLC)? A pilot study.
    Saikia J; Malik PS; Kumar S; Jain D; Madan K; Bharati SJ; Deo S; Kumar S
    J Surg Oncol; 2024 Jun; 129(7):1224-1234. PubMed ID: 38436618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-small-cell lung cancer prognosis using carcinoembryonic antigen levels in pleural lavage fluid.
    Tsutani Y; Yamashita Y; Misumi K; Ikeda T; Miyata Y; Okada M
    Eur J Cardiothorac Surg; 2012 Nov; 42(5):e96-101. PubMed ID: 22906597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer.
    Ai B; Liu H; Huang Y; Peng P
    Oncotarget; 2016 Jul; 7(28):44583-44595. PubMed ID: 27323821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profiling and utility of cell-free DNA in nonsmall carcinoma of the lung: Study in a tertiary care hospital.
    Ghosh M; Mukhopadhyay M; Das C; Chatterjee S; Naskar BG
    J Cancer Res Ther; 2021; 17(6):1389-1396. PubMed ID: 34916369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative pleural lavage: is it a valid prognostic factor in lung cancer?
    Vicidomini G; Santini M; Fiorello A; Parascandolo V; Calabrò B; Pastore V
    Ann Thorac Surg; 2005 Jan; 79(1):254-7; discussion 254-7. PubMed ID: 15620952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KMT2C promoter methylation in plasma-circulating tumor DNA is a prognostic biomarker in non-small cell lung cancer.
    Mastoraki S; Balgkouranidou I; Tsaroucha E; Klinakis A; Georgoulias V; Lianidou E
    Mol Oncol; 2021 Sep; 15(9):2412-2422. PubMed ID: 33159839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct profile of cell-free DNA in malignant pleural effusion of non-small cell lung cancer and its impact on clinical genetic testing.
    Yu Y; Qian J; Shen L; Ji W; Lu S
    Int J Med Sci; 2021; 18(6):1510-1518. PubMed ID: 33628109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of plasma cfDNA predicts clinical response in non-small cell lung cancer patients.
    Zhou X; Li C; Zhang Z; Li DY; Du J; Ding P; Meng H; Xu H; Li R; Ho E; Zhang A; Okunieff P; Lu J; Sha MY
    Sci Rep; 2021 Apr; 11(1):7633. PubMed ID: 33828112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of non-small-cell lung cancer patients with positive pleural lavage cytology.
    Nakao M; Hoshi R; Ishikawa Y; Matsuura Y; Uehara H; Mun M; Nakagawa K; Okumura S
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):777-82. PubMed ID: 25762707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of circulating cell-free DNA quantification and metabolic tumor burden in advanced non-small cell lung cancer.
    Hyun MH; Lee ES; Eo JS; Kim S; Kang EJ; Sung JS; Choi YJ; Park KH; Shin SW; Lee SY; Kim YH
    Lung Cancer; 2019 Aug; 134():158-166. PubMed ID: 31319975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between tumor mutations in cfDNA and survival in non-small cell lung cancer.
    Ottestad AL; Dai HY; Halvorsen TO; Emdal EF; Wahl SGF; Grønberg BH
    Cancer Treat Res Commun; 2021; 29():100471. PubMed ID: 34607221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive intraoperative pleural lavage cytology is a predictive marker of disease recurrence in stage I lung adenocarcinoma.
    Yanagawa N; Shiono S; Abiko M; Abe M; Watanabe K; Watanabe I; Uematsu M; Ogata SY; Sato T; Tamura G
    Interact Cardiovasc Thorac Surg; 2014 May; 18(5):621-5. PubMed ID: 24532312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative pleural lavage cytology is an independent prognostic indicator for staging non-small cell lung cancer.
    Lim E; Ali A; Theodorou P; Nicholson AG; Ladas G; Goldstraw P
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1113-8. PubMed ID: 15052210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of intraoperative detection of carcinoembryonic antigen mRNA in pleural lavage specimens from nonsmall cell lung cancer patients.
    Satoh Y; Sugai S; Uehara H; Mun M; Sakao Y; Okumura S; Nakagawa K; Ishikawa Y; Miki Y; Miyata S
    Thorac Cardiovasc Surg; 2012 Dec; 60(8):533-40. PubMed ID: 22252332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma cfDNA as a potential treatment monitoring and prognostic index in patients withnon-small cell lung cancer.
    Chen N; Li G; Li H; Xiang X; Guo G; Ma Q; Zhang Y
    Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):208-213. PubMed ID: 33040838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
    Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of intraoperative pleural lavage cytology for non-small cell lung cancer: the influence of positive pleural lavage cytology results on T classification.
    Kameyama K; Okumura N; Miyaoka E; Asamura H; Yoshino I; Tada H; Fujii Y; Nakanishi Y; Eguchi K; Mori M; Kobayashi H; Sawabata N; Okumura M; Yokoi K;
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2659-64. PubMed ID: 25173121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer.
    Balgkouranidou I; Chimonidou M; Milaki G; Tsarouxa EG; Kakolyris S; Welch DR; Georgoulias V; Lianidou ES
    Br J Cancer; 2014 Apr; 110(8):2054-62. PubMed ID: 24642624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic effect of single and multiple cancer-related somatic mutations in resected non-small-cell lung cancer.
    Jao K; Tomasini P; Kamel-Reid S; Korpanty GJ; Mascaux C; Sakashita S; Labbé C; Leighl NB; Liu G; Feld R; Bradbury PA; Hwang DM; Pintilie M; Tsao MS; Shepherd FA
    Lung Cancer; 2018 Sep; 123():22-29. PubMed ID: 30089591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleural lavage cytology in non-small cell lung cancer: lessons from 1000 consecutive resections.
    Okada M; Sakamoto T; Nishio W; Uchino K; Tsuboshima K; Tsubota N
    J Thorac Cardiovasc Surg; 2003 Dec; 126(6):1911-5. PubMed ID: 14688705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.